217 related articles for article (PubMed ID: 15288159)
1. Flecainide versus ibutilide for immediate cardioversion of atrial fibrillation of recent onset.
Reisinger J; Gatterer E; Lang W; Vanicek T; Eisserer G; Bachleitner T; Niemeth C; Aicher F; Grander W; Heinze G; Kühn P; Siostrzonek P
Eur Heart J; 2004 Aug; 25(15):1318-24. PubMed ID: 15288159
[TBL] [Abstract][Full Text] [Related]
2. [Immediate cardioversion of atrial fibrillation and atrial flutter lasting less than 90 days by ibutilide versus propafenone: a multicenter study].
Zhang HC; Guo JH; Fang Q; Zheng YA; Sun YM; Zhu WQ; Wan Z; Guo JX; Ge JB; Han SM
Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(12):798-801. PubMed ID: 15949393
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of repeated intravenous doses of ibutilide for rapid conversion of atrial flutter or fibrillation. Ibutilide Repeat Dose Study Investigators.
Stambler BS; Wood MA; Ellenbogen KA; Perry KT; Wakefield LK; VanderLugt JT
Circulation; 1996 Oct; 94(7):1613-21. PubMed ID: 8840852
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of intravenous ibutilide for rapid termination of atrial fibrillation and atrial flutter: a dose-response study.
Ellenbogen KA; Stambler BS; Wood MA; Sager PT; Wesley RC; Meissner MC; Zoble RG; Wakefield LK; Perry KT; Vanderlugt JT
J Am Coll Cardiol; 1996 Jul; 28(1):130-6. PubMed ID: 8752805
[TBL] [Abstract][Full Text] [Related]
5. Conversion efficacy and safety of intravenous ibutilide compared with intravenous procainamide in patients with atrial flutter or fibrillation.
Volgman AS; Carberry PA; Stambler B; Lewis WR; Dunn GH; Perry KT; Vanderlugt JT; Kowey PR
J Am Coll Cardiol; 1998 May; 31(6):1414-9. PubMed ID: 9581743
[TBL] [Abstract][Full Text] [Related]
6. Use of ibutilide in cardioversion of patients with atrial fibrillation or atrial flutter treated with class IC agents.
Hongo RH; Themistoclakis S; Raviele A; Bonso A; Rossillo A; Glatter KA; Yang Y; Scheinman MM
J Am Coll Cardiol; 2004 Aug; 44(4):864-8. PubMed ID: 15312873
[TBL] [Abstract][Full Text] [Related]
7. Ibutilide to expedite ED therapy for recent-onset atrial fibrillation flutter.
Mountantonakis SE; Moutzouris DA; Tiu RV; Papaioannou GN; McPherson CA
Am J Emerg Med; 2006 Jul; 24(4):407-12. PubMed ID: 16787796
[TBL] [Abstract][Full Text] [Related]
8. Ibutilide with magnesium for conversion of atrial fibrillation or flutter in rheumatic heart disease patients: Ibutilide with magnesium for chemical cardioversion of atrial fibrillation or flutter.
Malviya A; Kapoor M; Sivam RKN; Khan SA; Pandey R; Kumar U; Ete T; Mishra A
Indian Heart J; 2020; 72(4):283-288. PubMed ID: 32861384
[TBL] [Abstract][Full Text] [Related]
9. Ibutilide: efficacy and safety in atrial fibrillation and atrial flutter in a general cardiology practice.
Eversole A; Hancock W; Johns T; Lopez LM; Conti CR
Clin Cardiol; 2001 Jul; 24(7):521-5. PubMed ID: 11444644
[TBL] [Abstract][Full Text] [Related]
10. The cost-effectiveness of ibutilide versus electrical cardioversion in the conversion of atrial fibrillation and flutter to normal rhythm.
Zarkin GA; Bala MV; Calingaert B; VanderLugt JT
Am J Manag Care; 1997 Sep; 3(9):1387-94. PubMed ID: 10178487
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of ibutilide for chemical cardioversion of atrial fibrillation and atrial flutter in cancer patients.
Bickford CL; Agarwal R; Urbauer DL; Durand JB; Lenihan DJ
Am J Med Sci; 2014 Apr; 347(4):277-81. PubMed ID: 23588261
[TBL] [Abstract][Full Text] [Related]
12. Chemical cardioversion of atrial fibrillation or flutter with ibutilide in patients receiving amiodarone therapy.
Glatter K; Yang Y; Chatterjee K; Modin G; Cheng J; Kayser S; Scheinman MM
Circulation; 2001 Jan; 103(2):253-7. PubMed ID: 11208685
[TBL] [Abstract][Full Text] [Related]
13. Conversion of recent-onset atrial fibrillation or flutter with amiodarone after ibutilide has failed: a rapid, efficient, and safe algorithm.
Dilaveris P; Synetos A; Giannopoulos G; Gialafos E; Stefanadis C
Ann Noninvasive Electrocardiol; 2005 Jul; 10(3):382-6. PubMed ID: 16029392
[TBL] [Abstract][Full Text] [Related]
14. Safety and efficacy of ibutilide in cardioversion of atrial flutter and fibrillation.
Nair M; George LK; Koshy SK
J Am Board Fam Med; 2011; 24(1):86-92. PubMed ID: 21209348
[TBL] [Abstract][Full Text] [Related]
15. Prospective comparison of flecainide versus sotalol for immediate cardioversion of atrial fibrillation.
Reisinger J; Gatterer E; Heinze G; Wiesinger K; Zeindlhofer E; Gattermeier M; Poelzl G; Kratzer H; Ebner A; Hohenwallner W; Lenz K; Slany J; Kuhn P
Am J Cardiol; 1998 Jun; 81(12):1450-4. PubMed ID: 9645896
[TBL] [Abstract][Full Text] [Related]
16. Ibutilide for pharmacological cardioversion of atrial fibrillation and flutter: impact of race on efficacy and safety.
Gowda RM; Punukollu G; Khan IA; Wilbur SL; Vasavada BC; Sacchi TJ
Am J Ther; 2003; 10(4):259-63. PubMed ID: 12845389
[TBL] [Abstract][Full Text] [Related]
17. Use of ibutilide for cardioversion of recent-onset atrial fibrillation and flutter in elderly.
Gowda RM; Khan IA; Punukollu G; Mendoza C; Wilbur SL; Vasavada BC; Sacchi TJ
Am J Ther; 2004; 11(2):95-7. PubMed ID: 14999360
[TBL] [Abstract][Full Text] [Related]
18. Clinical and cost comparison of ibutilide and direct-current cardioversion for atrial fibrillation and flutter.
Murdock DK; Schumock GT; Kaliebe J; Olson K; Guenette AJ
Am J Cardiol; 2000 Feb; 85(4):503-6, A11. PubMed ID: 10728961
[TBL] [Abstract][Full Text] [Related]
19. Cost effectiveness of ibutilide with prophylactic magnesium in the treatment of atrial fibrillation.
Coleman CI; Kalus JS; White CM; Spencer AP; Tsikouris JP; Chung JO; Kenyon KW; Ziska M; Kluger J; Reddy P
Pharmacoeconomics; 2004; 22(13):877-83. PubMed ID: 15329032
[TBL] [Abstract][Full Text] [Related]
20. Ibutilide: an antiarrhythmic agent for the treatment of atrial fibrillation or flutter.
Howard PA
Ann Pharmacother; 1999 Jan; 33(1):38-47. PubMed ID: 9972384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
